trial

Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes

NCTId NCT02188732
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 301 (actual)
Sponsored by Dartmouth-Hitchcock Medical Center
Primary completion 2021-07-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
301 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2015-01
Primary completion
2021-07-31
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
CBHH+ATCBHH+SMTCBHH

Sponsors

Dartmouth-Hitchcock Medical CenterLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Sites

2 total
Boston, United StatesCambridge, United States

Facts & assertions

4 sourced
Enrollment
301
Phase
NA
Primary Completion Date
2021-07-31
Status
COMPLETED
relationships
The graph out of here
drug
CBHH+AT
drug
CBHH+SMT
drug
CBHH
drug
lead_sponsor
Dartmouth-Hitchcock Medical Center
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Bipolar Disorder
indication
Schizoaffective Disorder
indication
Depression
indication